|
000
| 01142nam##2200253za#4500 |
|---|
| 001 | 9.698708 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20220107114848 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2014||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-23039-9 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-4/2-2013E-PDF |
|---|
| 110 | 2 |aCentre for Communicable Diseases and Infection Control (Canada) |
|---|
| 245 | 10|aI-Track : |h[electronic resource]|benhanced surveillance of HIV, hepatitis C and associated risk behaviours among people who inject drugs in Canada - phase 2 report |
|---|
| 260 | |aOttawa - Ontario : |bPublic Health Agency of Canada. |cMarch 2014. |
|---|
| 300 | |a248p.|bcoloured figs., glossary, references, tables |
|---|
| 500 | |aThe catalogue number (HP40-4/2-2013E-PDF) and ISBN (978-1-100-23039-9) have been inverted in this electronic publication. |
|---|
| 590 | |a14-25|b2014-06-20 |
|---|
| 690 | 07|aAIDS (disease)|2gcpds |
|---|
| 690 | 07|aHepatitis|2gcpds |
|---|
| 775 | 08|tI-Track : |w(CaOODSP)9.642711 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s1.72 MB|uhttps://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-4-2-2013-eng.pdf |
|---|